Q2 2019 Atara Biotherapeutics Inc Earnings Call Transcript
Good day, ladies and gentlemen, and welcome to the Atara Biotherapeutics Second Quarter 2019 Financial Results Conference Call. (Operator Instructions)
I would now like to turn the conference over to your host, Dr. John Craighead, Vice President, Investor Relations and Corporate Communications. You may begin.
Thank you, operator. Good morning, everyone, and welcome to the Atara Second Quarter 2019 Financial Results and Corporate Update Conference Call. Earlier this morning, we issued a press release providing an overview of the company's second quarter 2019 financial results and recent operational progress. This press release as well as an updated investor presentation, are available in the Investors & Media section of atarabio.com. I'm joined on the call today by Dr. Pascal Touchon, President and Chief Executive Officer; Utpal Koppikar, Chief Financial Officer; Dr. Chris Haqq, Chief Scientific Officer; and Dr. AJ Joshi, Chief Medical Officer. We'll begin with
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |